Literature DB >> 24915893

Cardiac neuronal imaging with ¹²³I-meta-iodobenzylguanidine in heart failure: implications of endpoint selection and quantitative analysis on clinical decisions.

Mario Petretta1, Teresa Pellegrino, Alberto Cuocolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24915893     DOI： 10.1007/s00259-014-2827-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  20 in total

1.  Key issues in end point selection for heart failure trials: composite end points.

Authors:  James D Neaton; Gerry Gray; Bram D Zuckerman; Marvin A Konstam
Journal:  J Card Fail       Date:  2005-10       Impact factor: 5.712

2.  The "gray zone" for the heart to mediastinum MIBG uptake ratio.

Authors:  Mario Petretta; Teresa Pellegrino; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2014-05-09       Impact factor: 5.952

Review 3.  End points for comparative effectiveness research in heart failure.

Authors:  Larry A Allen; John A Spertus
Journal:  Heart Fail Clin       Date:  2012-10-18       Impact factor: 3.179

4.  Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure.

Authors:  Teresa Pellegrino; Mario Petretta; Serena De Luca; Stefania Paolillo; Antonio Boemio; Raffaella Carotenuto; Maria Piera Petretta; Carmine di Nuzzo; Pasquale Perrone-Filardi; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-06-06       Impact factor: 9.236

5.  Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.

Authors:  Anna De Rosa; Sabina Pappatà; Teresa Pellegrino; Maria Fulvia De Leva; Gennaro Maddaluno; Giovanni Fiumara; Raffaella Carotenuto; Mario Petretta; Alessandro Filla; Giuseppe De Michele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-09       Impact factor: 9.236

6.  How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1987-02       Impact factor: 24.094

7.  Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition.

Authors:  Faiez Zannad; Wendy Gattis Stough; Bertram Pitt; John G F Cleland; Kirkwood F Adams; Nancy L Geller; Christian Torp-Pedersen; Bridget-Anne Kirwan; Ferenc Follath
Journal:  Eur Heart J       Date:  2008-02       Impact factor: 29.983

8.  A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.

Authors:  Tomoaki Nakata; Kenichi Nakajima; Shohei Yamashina; Takahisa Yamada; Mitsuru Momose; Shu Kasama; Toshiki Matsui; Shinro Matsuo; Mark I Travin; Arnold F Jacobson
Journal:  JACC Cardiovasc Imaging       Date:  2013-07

Review 9.  Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.

Authors:  Jennifer K Rogers; Stuart J Pocock; John J V McMurray; Christopher B Granger; Eric L Michelson; Jan Östergren; Marc A Pfeffer; Scott D Solomon; Karl Swedberg; Salim Yusuf
Journal:  Eur J Heart Fail       Date:  2013-12-18       Impact factor: 15.534

10.  Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study.

Authors:  Stefania Paolillo; Giuseppe Rengo; Gennaro Pagano; Teresa Pellegrino; Gianluigi Savarese; Grazia D Femminella; Marianna Tuccillo; Antonio Boemio; Emilio Attena; Roberto Formisano; Laura Petraglia; Francesco Scopacasa; Gennaro Galasso; Dario Leosco; Bruno Trimarco; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Diabetes Care       Date:  2013-03-25       Impact factor: 19.112
View more
  2 in total

1.  Dual isotope and multidetector camera: The best choices for a specific end-point.

Authors:  Roberta Assante; Wanda Acampa
Journal:  J Nucl Cardiol       Date:  2016-05-19       Impact factor: 5.952

2.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.